Eric Groen
Vermogen: 611 798 $ op 31-08-2026
Vermogen: 611 798 $ op 31-08-2026
Eric Groen is currently Secretary & Chief Compliance Officer at Genelux Corp.
since 2025.
Formerly, Mr. Groen was Regional General Counsel at Amgen, Inc. and General Counsel at Rani Therapeutics Holdings, Inc. Education includes undergraduate studies at the University of California, Santa Barbara and graduate studies at Harvard Law School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENELUX CORP. 0,52% | 16-06-2026 | 233.957 ( 0,52% ) | 611 798 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENELUX CORPORATION | Compliance Officer | 01-07-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| RANI THERAPEUTICS HOLDINGS, INC. | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau